169 related articles for article (PubMed ID: 21212064)
41. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.
Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N
Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639
[TBL] [Abstract][Full Text] [Related]
42. [Lynch syndrome: selection of families by microsatellite instability and immunohistochemistry].
Wielandt AM; Zárate AJ; Hurtado C; Orellana P; Alvarez K; Pinto E; Contreras L; Corvalán A; Kronberg U; López-Köstner F
Rev Med Chil; 2012 Sep; 140(9):1132-9. PubMed ID: 23354634
[TBL] [Abstract][Full Text] [Related]
43. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing.
Zhang L
J Mol Diagn; 2008 Jul; 10(4):301-7. PubMed ID: 18556776
[TBL] [Abstract][Full Text] [Related]
45. Lynch or not Lynch? Is that always a question?
Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
[TBL] [Abstract][Full Text] [Related]
46. Preoperative Screening of Colorectal Cancers Is As Accurate As Postoperative Screening for Detection of Lynch Syndrome.
Harrigan J; Davis C; Chauhan M; Buckles D; Saeed A; Kennedy K; Collins DL; Olyaee M; Madan R; Bansal A
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2372-2374.e1. PubMed ID: 32428707
[TBL] [Abstract][Full Text] [Related]
47. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
48. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test.
Schofield L; Watson N; Grieu F; Li WQ; Zeps N; Harvey J; Stewart C; Abdo M; Goldblatt J; Iacopetta B
Int J Cancer; 2009 Mar; 124(5):1097-102. PubMed ID: 19072991
[TBL] [Abstract][Full Text] [Related]
49. Informed consent and immunohistochemistry screening for Lynch syndrome.
Williams JL; Williams MS
Genet Med; 2011 Sep; 13(9):848-9. PubMed ID: 21885923
[No Abstract] [Full Text] [Related]
50. Population-based screening for Lynch syndrome in Western Australia.
Schofield L; Grieu F; Amanuel B; Carrello A; Spagnolo D; Kiraly C; Pachter N; Goldblatt J; Platell C; Levitt M; Stewart C; Salama P; Ee H; Raftopoulous S; Katris P; Threlfall T; Edkins E; Wallace M; Iacopetta B
Int J Cancer; 2014 Sep; 135(5):1085-91. PubMed ID: 24474394
[TBL] [Abstract][Full Text] [Related]
51. Influence of a patient decision aid on decisional conflict related to PSA testing: a structural equation model.
Stephens RL; Xu Y; Volk RJ; Scholl LE; Kamin SL; Holden EW; Stroud LA
Health Psychol; 2008 Nov; 27(6):711-721. PubMed ID: 19025266
[TBL] [Abstract][Full Text] [Related]
52. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
Hall MJ
J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087
[TBL] [Abstract][Full Text] [Related]
53. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
54. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
Ward RL; Hicks S; Hawkins NJ
J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
[TBL] [Abstract][Full Text] [Related]
55. [Clinical Outcome of Microsatellite Instability-High Patients Treated with Pembrolizumab and Genetic Counseling].
Shimura S; Tsumura H; Araki N; Kawada R; Shimazu S; Waraya M; Yoshida T; Takada F; Iwamura M; Sasaki J
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1099-1104. PubMed ID: 36281602
[TBL] [Abstract][Full Text] [Related]
56. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
Mueller J; Gazzoli I; Bandipalliam P; Garber JE; Syngal S; Kolodner RD
Cancer Res; 2009 Sep; 69(17):7053-61. PubMed ID: 19690142
[TBL] [Abstract][Full Text] [Related]
59. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
[TBL] [Abstract][Full Text] [Related]
60. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
